Ask AI
ProCE Banner Activity

CE / CME

Better Together: A Collaborative Approach to Boosting RSV Vaccine Uptake in Adults

Video

Watch and learn as experts discuss strategies for boosting RSV vaccine uptake in adults. This on-demand session reviews the burden of RSV in adults, including who is at highest risk for severe disease, and summarizes the latest recommendations and evidence for adult RSV vaccination. Faculty also explore practical patient-centered and team-based strategies to communicate vaccine benefits and risks, address barriers, and improve uptake across care settings.

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Registered Nurses AANP : 1.00 AANP contact {hour}

Nurse Practitioners/Nurses: 0.25 hour of pharmacotherapy credit

Released: June 10, 2026

Expiration: June 09, 2027

Share

Provided by

Provided by Partners for Advancing Clinical Education (Partners) and the American Association of Nurse Practitioners in partnership with Decera Clinical Education

ProCE Banner
ProCE Banner

Supporters

This educational activity is supported by an independent medical education grant from GSK.

GSK

Partners

Decera Clinical Education

ProCE Banner

Target Audience

This activity is intended for nurse practitioners, physician associates, and other healthcare professionals practicing in primary and specialty care who are involved in the care of adults in need of RSV vaccination.

Program Learning Goal

The goal of this activity is to improve learners’ knowledge and competence regarding strategies to optimize uptake of RSV vaccination in adults.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply patient-centered strategies to discuss RSV risk and vaccination benefits with eligible adults 

  • Integrate the latest RSV vaccine recommendations into clinical practice 

  • Develop team-based approaches to improve RSV vaccine uptake among all eligible patients

  • Describe the efficacy, side effect profile, and indications/contraindications for RSV vaccination in adults

Disclosure

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

Primary Author

Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH: consultant/advisor/speaker: GSK, Pfizer, Shionogi.

Ruth Carrico, PhD, DNP, APRN, CIC, FSHEA, FNAP, FAAN: consultant/advisor/speaker: Dynavax, GSK, Moderna, Pfizer, Sanofi, Seqirus, Valneva; researcher: Sanofi. 

Jewel Mullen, MD, MPH, MPA, FACP, has no relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from June 10, 2026, through June 09, 2027:

  1. Login or Sign Up for an account by clicking at the top of this page.

  2. Read the target audience, learning objectives, and faculty disclosures.

  3. View and study the content in its entirety.

  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer

Learners have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement 

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners)and the American Association of Nurse Practitioners. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education(ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

This activity is approved for 1.0 contact hour(s) of continuing education (which​ includes 0.25 hour(s) of pharmacology) by the American Association of Nurse​ Practitioners® (AANP). Activity ID#: 26057798. This activity was planned in​accordance with AANP Accreditation Standards and Policies.

Physician Associate Continuing Medical Education

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/672d0c7c14643.png

Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credit. Approval is valid until June 09, 2027. PAs should only claim credit commensurate with the extent of their participation.